Business
Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp
FRANKLIN, Tenn. & BURLINGTON, N.C., July 22, 2025--Community Health Systems, Inc. (Company) (NYSE: CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered into a definitive agreement with Labcorp (NYSE: LH), pursuant to which Labcorp will acquire select assets and assume certain leases of the ambulatory outreach laboratory services of CHS health systems in 13 states, including certain patient service centers and in-office phlebotomy locations, for $195 mil
About this update from Labcorp Holdings Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/6eb401cc82452bb520e173b1ce02467b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/lngJsvNp4R6EW.UiVpNQ_g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6eb401cc82452bb520e173b1ce02467b","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/9fGGtKiSDU..QBabv13Csw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/6eb401cc82452bb520e173b1ce02467b","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Agreement aims to provide broader access to testing and laboratory services to communities across the U.S.","length":106,"tagName":"p","attribs":{}},{"type":"text","content":"FRANKLIN, Tenn. & BURLINGTON, N.C., July 22, 2025--(BUSINESS WIRE)--Community Health Systems, Inc. (Company) (NYSE: CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered into a definitive agreement with Labcorp (NYSE: LH), pursuant to which Labcorp will acquire select assets and assume certain leases of the ambulatory outreach laboratory services of CHS health systems in 13 states, including certain patient service centers and in-office phlebotomy locations, for $195 million cash.","length":531,"tagName":"p"},{"type":"text","content":"When the transaction is complete, CHS patients and providers will benefit from broader access to Labcorp’s comprehensive testing and laboratory services, including its specialty testing menu, robust data analytics and digital tools. CHS health systems will continue to operate their inpatient and emergency department laboratories and will continue to provide laboratory services for hospital-based services, such as imaging and pre-admission testing.","length":451,"tagName":"p"},{"type":"text","content":""We are excited about this transaction with Labcorp, which allows us to focus on our core services and improve the overall patient experience, aligning with our unwavering commitment to providing high-quality, accessible healthcare to our communities," said Kevin Stockton, Executive Vice President, Operations and Development for CHS. "Labco...